Compare SAVA & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAVA | ZVIA |
|---|---|---|
| Founded | 1998 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.1M | 96.4M |
| IPO Year | N/A | 2021 |
| Metric | SAVA | ZVIA |
|---|---|---|
| Price | $2.03 | $1.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $5.00 | $4.93 |
| AVG Volume (30 Days) | 620.4K | ★ 635.1K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 55.88 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $161,259,000.00 |
| Revenue This Year | N/A | $8.33 |
| Revenue Next Year | N/A | $6.84 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 4.01 |
| 52 Week Low | $1.15 | $1.11 |
| 52 Week High | $4.98 | $3.66 |
| Indicator | SAVA | ZVIA |
|---|---|---|
| Relative Strength Index (RSI) | 43.01 | 33.69 |
| Support Level | $2.01 | $1.11 |
| Resistance Level | $2.29 | $2.76 |
| Average True Range (ATR) | 0.14 | 0.10 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 13.21 | 44.92 |
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.